SEBASTIAN WINOCOUR to Scleroderma, Systemic
This is a "connection" page, showing publications SEBASTIAN WINOCOUR has written about Scleroderma, Systemic.
Connection Strength
0.182
-
CD109, a novel TGF-? antagonist, decreases fibrotic responses in a hypoxic wound model. Exp Dermatol. 2014 Jul; 23(7):475-9.
Score: 0.095
-
CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Arthritis Rheum. 2013 May; 65(5):1378-83.
Score: 0.087